Dec 29 (Reuters) - Ultragenyx Pharmaceutical (RARE.O), opens new tab said on Monday that late-stage studies showed its drug for a type of genetic bone disease failed to reduce the number of fractures ...
When a bone break is too severe to heal on its own, surgeons often rely on grafts or rigid metal implants — but both come with serious drawbacks. Now, researchers at ETH Zurich have created a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results